159 related articles for article (PubMed ID: 9407769)
1. Clinics in diagnostic imaging (29). Thalassaemia major with iron overload.
Griffith JF; King AD; Chan YL
Singapore Med J; 1997 Sep; 38(9):402-4. PubMed ID: 9407769
[TBL] [Abstract][Full Text] [Related]
2. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events.
Patton N; Brown G; Leung M; Bavishi K; Taylor J; Lloyd J; Lee SH; Tay L; Worthley S
Intern Med J; 2010 Jun; 40(6):419-26. PubMed ID: 19460052
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
4. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
Kumar P; Jagannathan NR; Choudhry VP
J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant micronutrients in children with thalassaemia in Egypt.
Nasr MR; Ali S; Shaker M; Elgabry E
East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
[TBL] [Abstract][Full Text] [Related]
6. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
7. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
[TBL] [Abstract][Full Text] [Related]
9. Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction.
Chouliaras GL; Kattamis A; Berdoukas V; Gotsis ED; Mavrogeni S; Ladis V
Br J Haematol; 2010 Nov; 151(4):397-401. PubMed ID: 20813008
[TBL] [Abstract][Full Text] [Related]
10. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.
Origa R; Barella S; Argiolas GM; Bina P; Agus A; Galanello R
Haematologica; 2008 Jul; 93(7):1095-6. PubMed ID: 18508795
[No Abstract] [Full Text] [Related]
11. Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients.
Taher AT; Musallam KM; Wood JC; Cappellini MD
Am J Hematol; 2010 Apr; 85(4):288-90. PubMed ID: 20143405
[No Abstract] [Full Text] [Related]
12. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.
Xu LH; Fang JP; Xu HG; Weng WJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):702-7. PubMed ID: 21970505
[TBL] [Abstract][Full Text] [Related]
14. Heart rate variability in β-thalassaemia major with or without cardiac siderosis.
Alp A; Ozdogan O; Guloglu CC; Turker M; Atabay B
Cardiol Young; 2014 Apr; 24(2):263-7. PubMed ID: 23402458
[TBL] [Abstract][Full Text] [Related]
15. Concurrent β-thalassaemia trait and Southeast Asian ovalocytosis associated with clinically significant iron loading.
Chen Y; Law HY; Tan GP; Ang AL
Blood Cells Mol Dis; 2017 Mar; 63():25-26. PubMed ID: 28024237
[No Abstract] [Full Text] [Related]
16. Brain natriuretic peptide as marker of myocardial iron load in beta-thalassemia.
Nikolidakis S; Flessa C; Nikolaou N; Gotsis ED; Koutouzis M; Polyhronaki E; Vrettou E; Kyriakides ZS
Int J Cardiol; 2007 Jun; 118(3):408-9. PubMed ID: 17045671
[TBL] [Abstract][Full Text] [Related]
17. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
Karamifar H; Shahriari M; Sadjadian N
East Mediterr Health J; 2003; 9(1-2):55-60. PubMed ID: 15562733
[TBL] [Abstract][Full Text] [Related]
19. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
[TBL] [Abstract][Full Text] [Related]
20. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
